The University of Toronto Medical Journal is a prominent publication within the field of General Medicine, dedicated to the dissemination of innovative research and critical discourse relevant to the medical community. Established in 1945 and published by the University of Toronto Medical Society, this journal serves as a platform for medical students and professionals to share their insights, fostering an environment of learning and collaboration. Over the years, the journal has played a crucial role in nurturing future leaders in medicine, contributing significantly to the academic landscape, despite its current Scopus rank of #511 out of 636 in its category, reflecting its niche yet vital presence. With an ISSN of 0833-2207 and an E-ISSN of 1913-5440, the journal remains a reference point for those passionate about medical research and education in Canada and beyond. Although it does not operate under an open-access model, the journal’s commitment to academic rigor and integrity continues to make it an essential resource for students, researchers, and healthcare professionals alike.

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.

Toxin Reviews is a premier academic journal focused on the critical field of Toxicology, published by Taylor & Francis Inc. Established with an aim to foster research and disseminate knowledge, this journal has been pivotal since its inception in 1982 and continues to be a leading platform for both emerging and established researchers. With an impressive impact factor and ranked in the 75th percentile among its peers in the Scopus categories, it serves as an essential resource for scientists, practitioners, and students interested in understanding the complexities of toxins and their effects on health. The journal provides an Open Access platform, enhancing visibility and accessibility of research findings to a broader audience. Covering a wide scope, Toxin Reviews plays a vital role in bridging gaps between toxicological research and practical applications, ensuring that rigorous scientific inquiry translates into real-world solutions.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

CLINICAL TOXICOLOGY is a prestigious journal dedicated to advancing the field of toxicology, published by Taylor & Francis Ltd. With ISSN 1556-3650 and E-ISSN 1556-9519, it has been a vital resource for researchers, clinicians, and students since its inception in 1968. The journal is recognized for its high impact, boasting a Q1 quartile ranking in both the categories of Medicine (miscellaneous) and Toxicology as of 2023, reflecting its reputation for disseminating significant contributions to the field. CLINICAL TOXICOLOGY primarily features original research, reviews, and case reports that explore the latest advancements and methodologies in the diagnosis and management of toxic exposures, making it an essential tool for professionals seeking to stay abreast of current trends and best practices. The journal's open access options ensure that its content is readily available to a wide audience, thereby promoting the exchange of knowledge and collaborative efforts within the global scientific community. For those committed to improving public health outcomes through toxicological research, CLINICAL TOXICOLOGY provides an indispensable platform for publication and discourse.

YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.

Welcome to the Italian Journal of Medicine, a distinguished publication in the realm of medical research and practice, diligently published by PAGEPRESS PUBL since 2007. This journal serves as a vital platform for the dissemination of innovative research findings, clinical studies, and reviews, providing an essential resource for researchers, healthcare professionals, and medical students alike. With an ISSN of 1877-9344 and an E-ISSN of 1877-9352, the journal embraces an Open Access model, ensuring that knowledge is accessible to all and promoting collaboration across the global medical community. While it currently holds a Q4 ranking in the miscellaneous category of medicine and a respectable rank of #372 out of 636 in General Medicine according to Scopus metrics, the Italian Journal of Medicine remains committed to improving its impact and reach in the scientific landscape. Situated in Pavia, Italy, the journal aims to bridge the gap between research and practice, fostering advancements that ultimately enhance patient care.

Welcome to the Cyprus Journal of Medical Sciences, a distinguished publication dedicated to the advancement of medical knowledge and research. Published by GALENOS PUBL HOUSE, this journal endeavors to uphold the highest standards of scientific inquiry in the medical field. With its ISSN 2149-7893 and E-ISSN 2536-507X, the journal serves as an essential resource for researchers, healthcare professionals, and students seeking to stay abreast of innovative findings and clinical practices. Although currently not listed under Open Access, this journal prioritizes rigorous peer review and the dissemination of impactful research aimed at driving improvements in medical science. The journal welcomes submissions that cover diverse areas within the medical realm, contributing to a more profound understanding of healthcare challenges and solutions. Join us in exploring the frontiers of medical sciences and contributing to a healthier future.

International Journal of Medical Toxicology and Forensic Medicine, published by Shaheed Beheshti Medical University of Medical Sciences & Health Services, is a pioneering platform dedicated to advancing knowledge within the critical fields of toxicology and forensic medicine. Established as an Open Access journal since 2011, it ensures wide dissemination of research findings, catering to a global audience of researchers, healthcare professionals, and students. With an ISSN of 2251-8762 and an E-ISSN of 2251-8770, the journal covers a diverse range of topics relevant to the medical community, albeit being categorized as Q4 in both Pathology and Forensic Medicine and Toxicology in 2023, indicating emerging significance in these disciplines. Geographically based in Tehran, Iran, it aspires to bridge gaps in scientific research and practice, particularly in regions where such expertise is critical. The journal welcomes submissions that investigate pressing issues in medical toxicology and forensic science, fostering an interdisciplinary dialogue essential for innovative solutions and improved public health outcomes.